Drug Repurposing in Parkinson’s Disease

CNS Drugs - United Kingdom
doi 10.1007/s40263-018-0548-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

In Silicomethods for Drug Repurposing and Pharmacology

Wiley Interdisciplinary Reviews: Systems Biology and Medicine
BiochemistryMedicineGeneticsMolecular Biology
2016English

Drug Repurposing With Network Reinforcement

BMC Bioinformatics
BiochemistryApplied MathematicsComputer Science ApplicationsStructural BiologyMolecular Biology
2019English

Drug Repurposing for Gastrointestinal Stromal Tumor

Molecular Cancer Therapeutics
Cancer ResearchOncology
2013English

Pnd2 - Risk of Parkinson’s Disease (Pd) in Patients Taking Adrenergic Drug Treatments

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Nutraceuticals in Parkinson’s Disease

NeuroMolecular Medicine
Molecular NeuroscienceNeurologyMolecular MedicineCellular
2016English

Repurposing Metformin for Cardiovascular Disease

Circulation
Cardiovascular MedicinePhysiologyCardiology
2018English

Integration of Immunome With Disease Gene Network Reveals Pleiotropy and Novel Drug Repurposing Targets

2019English

Exploiting Large-Scale Drug-Protein Interaction Information for Computational Drug Repurposing

BMC Bioinformatics
BiochemistryApplied MathematicsComputer Science ApplicationsStructural BiologyMolecular Biology
2014English

Drug Repurposing as an Efficient Strategy in Drug Development – Example of CNS Area

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy